ARTICLE | Company News

Allergy, Ergomed in allergy deal

December 15, 2017 4:13 AM UTC

Allergy Therapeutics plc (LSE:AGY) partnered with Ergomed plc (LSE:ERGO) to co-develop three of Allergy's OralVac subligual immunotherapy treatments. The OralVac products are marketed in Germany and other European countries on a named-patient basis, in which the physician obtains the therapy directly from the manufacturer before marketing authorization...